MGMT: its role in cancer aetiology and cancer therapeutics
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 4 (4) , 296-307
- https://doi.org/10.1038/nrc1319
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- ENU Mutagenesis: Analyzing Gene Function in MiceAnnual Review of Genomics and Human Genetics, 2001
- Ribozyme and free alkylated base: a dual approach for sensitizing Mex+ cells to the alkylating antineoplastic drugCancer Gene Therapy, 2000
- Mice over-expressing human O6alkylguanine-DNA alkyltransferase selectively reduce O6methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosoureaOncogene, 1999
- Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferasePharmacogenetics, 1999
- Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferaseOncogene, 1997
- Organization and Expression of the Mouse Gene for DNA Repair MethyltransferaseDNA and Cell Biology, 1996
- Detection and Measurement of Nucleotide Excision Repair Synthesis by Mammalian Cell Extracts in VitroMethods, 1995
- Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colonCarcinogenesis: Integrative Cancer Research, 1995
- In vivo formation and repair of O6 in human leukocyte DNA after intravenous exposure to dacarbazineCarcinogenesis: Integrative Cancer Research, 1991
- DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosoureaCarcinogenesis: Integrative Cancer Research, 1990